Hyperprogressive Disease After Treatment With Checkpoint Inhibitors
Immunotherapy, immune checkpoint inhibitors (ICIs) in particular, has dramatically changed the treatment and outcome of patients with many forms of cancer, including non–small cell lung cancer (NSCLC). The mechanism of action of these agents is to exert an antitumor immunity through T cells that…